‘Precious’ breast cancer drug withheld from NHS in price row
- Posted on August 23, 2025
- By The Times
- 5 Views
‘Precious’ breast cancer drug withheld from NHS in price row
The pharma giant Gilead Sciences will not send Trodelvy for assessment by the UK drugs watchdog, claiming it can’t make enough profit in Britain
